Liquid crystal compound having butene-bonding group, liquid crystal composition and liquid crystal display device

US10047293B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10047293-B2
Application numberUS-201514821175-A
CountryUS
Kind codeB2
Filing dateAug 7, 2015
Priority dateAug 8, 2014
Publication dateAug 14, 2018
Grant dateAug 14, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

To provide a liquid crystal compound satisfying at least one of high stability to heat, light and so forth, a high clearing point, low minimum temperature of a liquid-crystal phase, small viscosity, suitable optical anisotropy, large dielectric anisotropy, a suitable elastic constant and excellent compatibility with other liquid-crystal compounds, a liquid crystal composition containing the compound and a liquid crystal display device including the composition. A compound is represented by formula (1-1). For example, R 1 and R 2 are independently hydrogen, alkyl having 1 to 10 carbons, alkenyl having 3 to 10 carbons and alkoxy having 1 to 9 carbons; ring A 1 is 1,4-cyclohexylene; ring A 2 and ring A 3 are independently 1,4-cyclohexylene or 1,4-phenylene; Z 1 is a single bond or —(CH 2 ) 2 ; l is 0 or 1, m and n are 0, 1 or 2, a sum: l+m+n is 0, 1 or 2; x is 0 or 1.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound represented by any one of formulas (1-4-4) to (1-4-6): wherein, in formulas (1-4-4) to (1-4-6), R 1 is alkyl having 1 to 10 carbons, R 2 is alkyl having 1 to 10 carbons or alkoxy having 1 to 9 carbons. 2. A liquid crystal composition, containing at least one of the compounds according to claim 1 . 3. The liquid crystal composition according to claim 2 , further containing at least one compound selected from the group of compounds represented by each of formulas (2), (3) and (4): wherein, in formulas (2) to (4), R 11 is alkyl having 1 to 10 carbons or alkenyl having 2 to 10 carbons, and in the alkyl and the alkenyl, at least one of hydrogen may be replaced by fluorine, and at least one of —CH 2 — may be replaced by —O—; X 11 is fluorine, chlorine, —OCF 3 , —OCHF 2 , —CF 3 , —CHF 2 , —CH 2 F, —OCF 2 CHF 2 or —OCF 2 CHFCF 3 ; ring B 1 , ring B 2 and ring B 3 are independently 1,4-cyclohexylene, 1,4-phenylene in which at least one of hydrogen may be replaced by fluorine, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl or pyrimidine-2,5-diyl; Z 11 , Z 12 , and Z 13 are independently a single bond, —CH 2 CH 2 —, —CH═CH—, —C≡C—, —COO—, —CF 2 O—, —OCF 2 —, —CH 2 O— or —(CH 2 ) 4 —; and L 11 and L 12 are independently hydrogen or fluorine. 4. The liquid crystal composition according to claim 2 , further containing at least one compound selected from the group of compounds represented by formula (5): wherein, in formula (5), R 12 is alkyl having 1 to 10 carbons or alkenyl having 2 to 10 carbons, and in the alkyl and the alkenyl, at least one of hydrogen may be replaced by fluorine and at least one of —CH 2 — may be replaced by —O—; X 12 is —C≡N or —C≡C—C≡N; ring C 1 is 1,4-cyclohexylene, 1,4-phenylene in which at least one of hydrogen may be replaced by fluorine, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl or pyrimidine-2,5-diyl; Z 14 is a single bond, —CH 2 CH 2 —, —C≡C—, —COO—, —CF 2 O—, —OCF 2 — or —CH 2 O—; L 13 and L 14 are independently hydrogen or fluorine; and i is 1, 2, 3 or 4. 5. The liquid crystal composition according to claim 2 , further containing at least one compound selected from the group of compounds represented by formulas (6) to (12): wherein, in formulas (6) to (12), R 13 and R 14 are independently alkyl having 1 to 10 carbons or alkenyl having 2 to 10 carbons, and in the alkyl or the alkenyl, at least one of —CH 2 — may be replaced by —O— and at least one of hydrogen may be replaced by fluorine; R 15 is hydrogen, fluorine, alkyl having 1 to 10 carbons or alkenyl having 2 to 10 carbons, and in the alkyl and the alkenyl, at least one of —CH 2 — may be replaced by —O— and at least one of hydrogen may be replaced by fluorine; S 11 is hydrogen or methyl; X is —CF 2 —, —O— or —CHF—; ring D 1 , ring D 2 , ring D 3 and ring D 4 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene in which at least one of hydrogen may be replaced by fluorine, tetrahydropyran-2,5-diyl or decahydronaphthalene-2,6-diyl; ring D 5 and ring D 6 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, tetrahydropyran-2,5-diyl or decahydronaphthalene-2,6-diyl; Z 15 , Z 16 , Z 17 and Z 18 are independently a single bond, —CH 2 CH 2 —, —COO—, —CH 2 O—, —OCF 2 — or —OCF 2 CH 2 CH 2 —; L 15 and L 16 are independently fluorine or chlorine; and j, k, m, n, p, q, r and s are independently 0 or 1, a sum of k, m, n and p is 1 or 2, a sum of q, r and s is 0, 1, 2 or 3, and t is 1, 2 or 3. 6. The liquid crystal composition according to claim 2 , further containing at least one compound selected from the group of compounds represented by formulas (13) to (15): wherein, in formulas (13) to (15), R 16 and R 17 are independently alkyl having 1 to 10 carbons or alkenyl having 2 to 10 carbons, and in the alkyl and the alkenyl, at least one of —CH 2 — may be replaced by —O— and at least one of hydrogen may be replaced by fluorine; ring E 1 , ring E 2 , ring E 3 and ring E 4 are independently 1,4-cyclohexylene, 1,4-phenylene, 2-fluoro-1,4-phenylene, 2,5-difluoro-1,4-phenylene or pyrimidine-2,5-diyl; and Z 19 , Z 20 and Z 21 are independently a single bond, —CH 2 CH 2 —, —CH═CH—, —C≡C— or —COO—: 7. The liquid crystal composition according to claim 2 , further containing at least one optically active compound and/or at least one polymerizable compound. 8. The liquid crystal composition according to claim 2 , further containing at least one antioxidant and/or at least one ultraviolet light absorbent. 9. A liquid crystal display device, including the liquid crystal composition according to claim 2 .

Assignees

Inventors

Classifications

  • Cy-Cy-COO-Ph-Ph · CPC title

  • Cy-Cy-Ph-Ph · CPC title

  • Compounds containing a naphthalene ring or a completely or partially hydrogenated naphthalene ring · CPC title

  • chain containing -COO- or -OCO- groups · CPC title

  • in which the rings are linked by a chain containing carbon and oxygen atoms, e.g. esters or ethers · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10047293B2 cover?
To provide a liquid crystal compound satisfying at least one of high stability to heat, light and so forth, a high clearing point, low minimum temperature of a liquid-crystal phase, small viscosity, suitable optical anisotropy, large dielectric anisotropy, a suitable elastic constant and excellent compatibility with other liquid-crystal compounds, a liquid crystal composition containing the com…
Who is the assignee on this patent?
Jnc Corp, Jnc Petrochemical Corp
What technology area does this patent fall under?
Primary CPC classification C09K19/3402. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).